Brain-Sparing Sympathofacilitators Mitigate Obesity without Adverse Cardiovascular Effects

Anti-obesity drugs in the amphetamine (AMPH) class act in the brain to reduce appetite and increase locomotion. They are also characterized by adverse cardiovascular effects with origin that, despite absence of any in vivo evidence, is attributed to a direct sympathomimetic action in the heart. Here...

Descripción completa

Detalles Bibliográficos
Autores principales: Mahú, Inês, Barateiro, Andreia, Rial-Pensado, Eva, Martinéz-Sánchez, Noelia, Vaz, Sandra H., Cal, Pedro M.S.D., Jenkins, Benjamin, Rodrigues, Tiago, Cordeiro, Carlos, Costa, Miguel F., Mendes, Raquel, Seixas, Elsa, Pereira, Mafalda M.A., Kubasova, Nadiya, Gres, Vitka, Morris, Imogen, Temporão, Carolina, Olivares, Marta, Sanz, Yolanda, Koulman, Albert, Corzana, Francisco, Sebastião, Ana M., López, Miguel, Bernardes, Gonçalo J.L., Domingos, Ana I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cell Press 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7671941/
https://www.ncbi.nlm.nih.gov/pubmed/32402266
http://dx.doi.org/10.1016/j.cmet.2020.04.013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7671941/
https://www.ncbi.nlm.nih.gov/pubmed/32402266
http://dx.doi.org/10.1016/j.cmet.2020.04.013

Ejemplares similares